Device type · NPU
Prosthesis, Mitral Valve, Percutaneously Delivered
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NPU
Cardiovascular
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
504
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Prosthesis, Mitral Valve, Percutaneously Delivered
- Product code
- NPU
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for NPU
Latest FDA decisions
- SAPIEN M3 Transcatheter Mitral Valve Replacement SystemBreakthroughPMA
P250019 · Decided Dec 22, 2025 · 180 days after receipt
Device type: Prosthesis, mitral valve, percutaneously delivered (NPU) · Cardiology
- Tendyne Transcatheter Mitral Valve SystemBreakthroughPMA
P240042 · Decided May 23, 2025 · 177 days after receipt
Device type: Prosthesis, mitral valve, percutaneously delivered (NPU) · Cardiology
- Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve SystemsPMA supplement
P140031-S162 · Decided May 23, 2024 · 296 days after receipt · Panel Track
Device type: Prosthesis, mitral valve, percutaneously delivered (NPU) · Cardiology
Reports received
504
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
29
5.8% of reports
Injury reports
405
80% of reports
Death reports
70
14% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 28 | 19 | 0 |
| Jan 24 | 1 | 10 | 0 | 0 |
| Feb 24 | 0 | 6 | 2 | 0 |
| Mar 24 | 3 | 27 | 11 | 0 |
| Apr 24 | 5 | 12 | 0 | 0 |
| May 24 | 4 | 12 | 3 | 0 |
| Jun 24 | 2 | 37 | 8 | 0 |
| Jul 24 | 1 | 10 | 0 | 0 |
| Aug 24 | 1 | 30 | 15 | 0 |
| Sep 24 | 2 | 11 | 3 | 0 |
| Oct 24 | 1 | 13 | 0 | 0 |
| Nov 24 | 2 | 9 | 0 | 0 |
| Dec 24 | 4 | 26 | 9 | 0 |
| Jan 25 | 4 | 2 | 2 | 0 |
| Feb 25 | 0 | 12 | 0 | 0 |
| Mar 25 | 0 | 27 | 12 | 0 |
| Apr 25 | 1 | 9 | 2 | 0 |
| May 25 | 4 | 18 | 4 | 0 |
| Jun 25 | 2 | 23 | 11 | 0 |
| Jul 25 | 0 | 16 | 3 | 0 |
| Aug 25 | 2 | 8 | 2 | 0 |
| Sep 25 | 4 | 17 | 4 | 0 |
| Oct 25 | 5 | 29 | 15 | 0 |
| Nov 25 | 4 | 10 | 2 | 0 |
| Dec 25 | 3 | 43 | 15 | 0 |
| Jan 26 | 2 | 15 | 2 | 0 |
| Feb 26 | 1 | 37 | 6 | 0 |
| Mar 26 | 2 | 45 | 12 | 0 |
| Apr 26 | 3 | 28 | 7 | 0 |
| May 26 | 2 | 36 | 2 | 0 |
| Jun 26 | 0 | 34 | 2 | 0 |
| Jul 26 | 2 | 34 | 5 | 0 |
| Aug 26 | 2 | 38 | 2 | 0 |
| Sep 26 | 7 | 43 | 9 | 0 |
| Oct 26 | 1 | 42 | 6 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott37
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Perivalvular Leak138
- Adverse Event Without Identified Device or Use Problem85
- Patient Device Interaction Problem84
- Insufficient Device Problem Information51
- Malposition of Device44
- Device Stenosis33
- Migration or Expulsion of Device20
- Calcified17
- Degraded13
- Difficult to Remove12
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions131
- Insufficient Information92
- Cardiac Perforation46
- Thrombosis/Thrombus37
- Heart Failure/Congestive Heart Failure35
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available28
- Hemolysis25
- Dyspnea23
- Heart Block21
- Obstruction/Occlusion19
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0287-2027 · Started Oct 5, 2026 · Posted by FDA Nov 2, 2026
Reason given: Due to a manufacturing issue which may result in cardiovascular balloon rupturing.
Cause as FDA categorized it: Process change control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.